Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2017-11-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recently, it was shown that sVCAM-1/sICAM-1 ratio is a promising serum biomarker, which may lead to the development of a new, efficient, sensitive, non-invasive tool for diagnosing endometriosis, thereby potentially avoiding surgical interventions.
Primary aim: To determine whether the serum sVCAM-1/sICAM-1 ratio can be used todiagnose endometriosis.
Study design: Prospective multicenter validation study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Application of Probe-based Confocal Laser Endomicroscopy in the Diagnosis of Deep Endometriosis
NCT02547909
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
NCT01301885
Endometriosis and Complement System
NCT06495151
Value of Advanced MRI Techniques in the Assessment of Endometriosis
NCT06481982
Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis
NCT06298617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients
participants undergoing a diagnostic laparoscopy and have a histologically confirmed Endometriosis
No interventions assigned to this group
controls
participants undergoing a diagnostic laparoscopy where no evidence of Endometriosis could be found
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic pelvic pain
* suspicion of endometriosis
* cysts
* myomas
Exclusion Criteria
* malign diseases
* drug abuse
* pregnancy
* infectious diseases
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical-Scientific Fund of the Mayor of the Federal Capital Vienna
UNKNOWN
Heinrich Husslein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heinrich Husslein
Assoc.Prof.Priv.Doz Dr.med.univ. , PLL.M.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Heinrich Husslein, Dr.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1496/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.